From Charlestown, New Hampshire, USA:
I have a history of Polycystic Ovary Syndrome and insulin resistance, and since my hysterectomy my blood sugars have been in the diabetic range for type 2 diabetes, so I have started Glucophage on my doctor's advice. Since I know I will be eventually on insulin anyway, I would rather skip the whole Glucophage thing and just start insulin, but my endocrinologist says that's not a good idea.What would be the disadvantage of starting insulin treatment? I have a *very* strong family history, and my 55 year old father who has had type 2 diabetes for 15 years is in his last months of life, living on dialysis.
Glucophage [metformin] has the advantage of treating blood sugars and minimizing weight gain, compared to other agents, including insulin. It may be true that insulin would also treat high sugars, but it would be more difficult to use for mild elevations in glucose, and it will probably cause weight gain. The proof is in the result. If the Glucophage is successful, and your sugars normalize, I think it is reasonable to ride it out and continue the treatment. There is no evidence to suggest that normal blood sugars on insulin are superior to normal blood sugars on Glucophage.
By taking better care of yourself at an earlier age, the hope is that you can be spared any end-organ complications, such as kidney problems. I would suggest end-stage renal failure is not a sure thing for all people with diabetes. This includes those with a family history of renal failure from diabetes.
Last Updated: Tuesday April 06, 2010 15:09:48
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2016. Comments and Feedback.